Endometriosis and autoimmunity

Author:

Abisror Noémie1,Kolanska Kamila2ORCID,Cheloufi Meryem3,Selleret Lise2ORCID,d’Argent Emmanuelle2,Kayem Gilles3ORCID,Mekinian Arsene1ORCID

Affiliation:

1. 1Sorbonne Université, AP-HP, Hôpital Saint-Antoine, service de Médecine Interne and Inflammation-(DMU i3), 75012 Paris, France

2. 2Sorbonne Université, AP-HP, Hôpital Tenon, service de Gynécologie-Obstétrique et Médecine de la Reproduction, Université Paris 06, UMRS-938, 75020 Paris, France 3GRC-6 Centre Expert En Endométriose (C3E), Sorbonne Université, UMRS-938, 75020 Paris, France

3. 4Sorbonne Université, AP-HP, Hôpital Trousseau, service d’Obstétrique, Université Paris 06, 75012 Paris, France

Abstract

Endometriosis is an inflammatory oestrogen-dependent chronic disease and is mainly expressed by pain and increased infertility. Several studies showed an increased prevalence of autoimmune systemic diseases and various autoantibodies in endometriosis. The association of these autoimmune markers and diseases could raise the fact that endometriosis is an authentic autoimmune or inflammatory disease and thus could argue for the use of immunomodulatory therapies. Usually, it is considered that the autoantibodies did not directly act in endometrium implants growth, and could be rather implicated in endometriosis-related infertility. The use of immunomodulatory strategies could be an important alternative or additional strategy to the use of hormones and surgery but need prospective well-designed trials.

Publisher

Open Exploration Publishing

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3